Figure 2
The proportion of progression (newly diagnosed or worsened severity) in non-alcoholic fatty liver disease (NAFLD) after menopausal hormone therapy (MHT) based on route of estrogen administration. P value based on chi-square test.
Figure 2 | Scientific Reports
